*Screening of healthy population not included. IMPACT OF DIABETES HEALTH SYSTEM & ECONOMIC SAVINGS 25.8 million Americans $245 billion a year¹ AFFECTS= COSTS= annual savings /person affected $5,886 $34.9M increased tax revenue Use of insulin pumps for treatment of people with diabetes generates net cost savings, providing better disease management. $ thousands 2005 2006 2007 2008 2009 2010 10 15 20 25 30 35 40 45 22.3 27.5 29.0 35.6 27.7 39.0 24.9 30.6 22.8 29.4 24.9 30.4 Insulin pump Insulin, no pump * Includes treatment expenditures and indirect impacts. AVERAGE ANNUAL ECONOMIC BURDEN 2008-2010 ($) Insulin pump $24,217.5 Insulin, no pump $30,103.2 Average savings $5,885.8 1. American Diabetes Association. Economic Cost of Diabetes in the US in 2012. [published online ahead of print March 6, 2013] Diabetes Care. DOI:10.2337/dc12-26255. GAIN LOSS $101.1 billion $225.4 billion 0 5 10 15 20 25 30 35 40 45 $ billions 0.00 2.74 7.85 15.76 26.97 42.13 2010 2015 2020 2025 2030 2035 -25.0 -20.0 -15.0 -10.0 -5.0 0.0 $ billions -23.52 -12.65 -6.35 -2.79 -0.84 0.00 2010 2015 2020 2025 2030 2035 THE FUTURE ECONOMIC IMPACT OF INSULIN DEPENDENT DIABETES, 2005-2010* Per Person Affected HEALTHY SAVINGS: MEDICAL TECHNOLOGY & THE ECONOMIC BURDEN OF DISEASE Increased incentives for medical technology investment used to treat diabetes will generate even larger net savings over time. Reduced incentives for medical technology used to treat diabetes will result in larger net costs. Study by Milken Institute. Authors: Anusuya Chatterjee, Jaque King, Sindhu Kubendran, and Ross DeVol. To view the full study, visit: http://lifechanginginnovation.org/get-facts